why choose us

First received: May 08, 2023

Clinical Trial: PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Menstrual Bleeding, Heavy

Study Type: INTERVENTIONAL


Official Title: The Role of Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), Tissue Factor Pathway Inhibitor (TFPI), and Endometrial Endothelial Cells in Uterine Hemostasis in Humans

Brief Summary: The purpose of the study is to learn more about the role of blood clotting factor proteins and cells in menstrual (period) bleeding.The investigators are hoping to identify differences in these proteins and cells in the menstrual blood of individuals with heavy periods compared to menstruating individuals who do not have heavy periods.

Read more